Quick Takeaways
- Daniel Joseph Apel has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $11,716,127.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Daniel Joseph Apel
- Location
- Pasadena, CA
- Summary
- The estimated net worth of Daniel Joseph Apel is at least $11,716,127 dollars as of 24 Apr 2026. Daniel Joseph Apel is the Chief Financial Officer of ARROWHEAD PHARMACEUTICALS, INC. and owns shares of ARROWHEAD PHARMACEUTICALS, INC. (ARWR) stock worth about $11.72M.
- Signature
- /s/Daniel Joseph Apel
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Daniel Joseph Apel and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: ARROWHEAD PHARMACEUTICALS, INC. ($11,716,127).
- Past-year value change for that position: -$934,285.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Daniel Joseph Apel
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Chief Financial Officer | $11,716,127 | -$934,285 | -7.4% | 22 Apr 2026 |
Insider Transactions Reported by Daniel Joseph Apel:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.